Source: Virtual Congress 2021 – COPD burden, epidemiology and management



Rating:

Share or cite this content

Citations should be made in the following way:
E. Ouaalaya (Bordeaux, France), M. Zysman (Bordeaux, France), É. Berteaud (Bordeaux, France), L. Falque (Bordeaux, France), E. Monge (Bordeaux, France), L. Nguyen (Bordeaux, France), A. Ozier (Bordeaux, France), J. Dupis (Pessac, France), M. Sabatini (Bayonne, France), C. Nocent-Ejnaini (Bayonne, France), L. Petrov (Bayonne, France), A. Bernady (Cambo les bains, France), C. Roy (Libourne, France), F. Le Guillou (La Rochelle, France), M. Aliati (Lormont, France), A. Prudhomme (Aressy, France), M. Quinquenel (Léognan, France), M. Staali (Libourne, France), F. Pilard (Libourne, France), E. Iglesias (Libourne, France), M. Sapène (Bordeaux, France), J. Casteigt (Saint-Médard-en-Jalles, France), J. Moinard (Bordeaux, France), Y. Daoudi (Saint-Médard-en-Jalles, France), É. Blanchard (Bordeaux, France), J. Macey (Bordeaux, France), R. Veillon (Bordeaux, France), X. Demant (Bordeaux, France), C. Bon (Bordeaux, France), L. Grassion (Bordeaux, France), M. Molimard (Bordeaux, France), C. Raherison-Semjen (Bordeaux, France). Identification and analysis of clinical phenotypes in COPD patients: PALOMB Cohort. 3502

Member's Comments

No comment yet.

Related content which might interest you: Identification of clinical phenotypes using cluster analyses in COPD patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Clinical COPD phenotypes identified by cluster analysis: validation with mortality Source: Eur Respir J 2012; 40: 495-496 Year: 2012 Identification of clinical phenotypes in patients with and without COPD using cluster analysis Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Longitudinal validation of clinical COPD phenotypes identified by cluster analysis Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort Source: International Congress 2017 – COPD: latest insights into the management of patients Year: 2017 Clinical characteristics and determinants of exacerbation in Japanese patients with COPD: Hokkaido COPD cohort study results Source: Annual Congress 2012 - COPD exacerbation Year: 2012 The superexacerbator phenotype in patients with COPD: a descriptive analysis Source: ERJ Open Res, 5 (2) 00235-2018; 10.1183/23120541.00235-2018 Year: 2019 Persistence of clinical criteria of chronic bronchitis in patients with COPD over time: A longitudinal analysis of the TRACE cohort. Source: International Congress 2017 – Markers of COPD progression Year: 2017 COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Metabolomic analysis of severe COPD. Study of biomarkers in the CHAIN cohort. Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Identifying a ‘frequent exacerbator‘ phenotype in a cohort of COPD patients (EXACO study) Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 Muscle phenotypes in COPD patients: An exploratory cluster analysis Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance Year: 2012 Definition and characterization of an inflammatory phenotype in patients with COPD - results from the COSYCONET study Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Phenotypes, treatable traits, GOLD groups and grades – how they predict mortality risk in COPD patients? (data from the Czech Multicenter Research Database of COPD) Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases Year: 2020 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Stable state MR-proadrenomedullin level in COPD patients; a validation study Source: International Congress 2014 – Comorbidities Year: 2014 Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014